Lithium succinate API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Lithium succinate API 29126-50-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Lithium succinate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Lithium succinate
- Synonyms:
- Butanedioic acid, dilithium salt , Dilithium succinate , Lithium succinate dibasic , Lithium succinate, dibasic , Succinic acid dilithium salt , Succinic acid, dilithium salt
- Cas Number:
- 29126-50-9
- DrugBank number:
- DB14508
- Unique Ingredient Identifier:
- MD64P82Y28
General Description:
Lithium succinate is a chemical compound identified by the CAS number 29126-50-9. It is known for its distinct pharmacological properties and applications.
Classification:
Lithium succinate belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups, classified under the direct parent group Dicarboxylic acids and derivatives. This compound is a part of the Organic compounds, falling under the Organic acids and derivatives superclass, and categorized within the Carboxylic acids and derivatives class, specifically within the Dicarboxylic acids and derivatives subclass.
Categories:
Lithium succinate is categorized under the following therapeutic classes: Acids, Acyclic, Dermatologicals, Dicarboxylic Acids, Lithium Compounds, Ointments. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Lithium succinate is a type of Dermatological Agents
Dermatological agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the formulation of various skincare and dermatology products. These APIs are specifically designed to target and treat skin conditions, offering effective solutions for a wide range of dermatological concerns.
Dermatological agents encompass a diverse array of compounds, including corticosteroids, antifungal agents, antibacterials, retinoids, and immunomodulators. Each API within this category possesses unique properties and mechanisms of action, enabling them to address specific skin-related issues.
Corticosteroids, for instance, are potent anti-inflammatory agents commonly used in the treatment of skin conditions like eczema, psoriasis, and dermatitis. Antifungal agents, on the other hand, combat fungal infections such as athlete's foot or ringworm. Antibacterials are effective against bacterial infections, while retinoids promote skin cell turnover and treat acne and photoaging. Immunomodulators regulate the immune response, providing relief from conditions like atopic dermatitis.
The development and application of dermatological APIs involve rigorous research, clinical trials, and regulatory compliance. These APIs are typically integrated into topical creams, ointments, gels, and lotions, ensuring targeted delivery to the affected areas of the skin.
Dermatological agents play a crucial role in the management and treatment of various skin disorders. By harnessing the therapeutic properties of these APIs, pharmaceutical companies can develop innovative skincare products that cater to the diverse needs of individuals seeking effective dermatological solutions.
